Cargando…

P1577: RISK FACTORS FOR MORTALITY IN CRITICALLY ILL PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN A POLYVALENT INTENSIVE CARE UNIT: A RETROSPECTIVE STUDY

Detalles Bibliográficos
Autores principales:	Dias, A. R., Gonçalves, J., Seganfredo, F., Gramaça, J., Rebelo, M., Carmo, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428961/ http://dx.doi.org/10.1097/01.HS9.0000849164.14810.65

Ejemplares similares

The Reality of Critical Cancer Patients in a Polyvalent Intensive Care Unit
por: Neves, Maria Teresa, et al.
Publicado: (2021)

COLLABORATION AGREEMENT NO. K1577
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2008)

Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients
por: Peyrony, Olivier, et al.
Publicado: (2019)

1577. Real-World, Multicenter Experience with Eravacycline for Various Infections
por: Alosaimy, Sara, et al.
Publicado: (2020)

Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
por: AYGENCEL, Gülbin, et al.
Publicado: (2021)

1577P Early mortality linked to COVID-19 in cancer patients as compared to historical control in pre-pandemic times
por: Dienstmann, R., et al.
Publicado: (2021)

Evaluation of risk factors for mortality in hematological malignancy patients admitted to intensive care unit
por: Ileri, I, et al.
Publicado: (2015)

Predictors of poor outcomes in critically ill patients with hematologic malignancy
por: Cornish, M, et al.
Publicado: (2015)

Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy
por: Cornish, Marion, et al.
Publicado: (2016)

Intensive care unit outcomes in patients with hematological malignancy
por: Rawson, Jarrod Leigh, et al.
Publicado: (2020)

Incidence and risk of falls in patients treated for hematologic malignancies in the Intensive Hematology Unit
por: Lorca, Luz Alejandra, et al.
Publicado: (2019)

PReS13-SPK-1577: 'Asia' - autoimmune (auto-inflammatory) syndromes induced by adjuvants
por: Shoenfeld, YY
Publicado: (2013)

Treatment Limitation Decisions in Critically Ill Patients With a Malignancy on the Intensive Care Unit
por: van der Zee, Esther N., et al.
Publicado: (2020)

Predictors of intensive care unit admission in patients with hematologic malignancy
por: Vijenthira, Abi, et al.
Publicado: (2020)

1577. Particle Characterization of Nebulized Liposomal Amphotericin B and Its Use in the Treatment of Murine Pulmonary Aspergillosis
por: Dave, Janam J, et al.
Publicado: (2019)

Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial
por: Vergnano, Beatrice, et al.
Publicado: (2023)

The role of vitamin d in patients with severe sars cov2 pneumonia admitted to a polyvalent intensive care unit. Prospective study on clinical and laboratory evolution and prognosis
por: Gonçalves, A.M., et al.
Publicado: (2023)

Achilles Pirmin Gasser (1505–1577) Arzt und Naturforscher Historiker und Humanist, Briefwechsel
Publicado: (1976)

Hematology and Oncology in Critical Illness
por: Brandão, Leonardo R., et al.
Publicado: (2011)

Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies
por: Seganfredo, Fernanda Braga, et al.
Publicado: (2022)

The prognostic factors for patients with hematological malignancies admitted to the intensive care unit
por: Cheng, Qian, et al.
Publicado: (2016)

The Value of Polyvalent Serum
por: Dunlop, C. W.
Publicado: (1912)

Serum Estradiol Level at Intensive Care Unit Admission and Mortality in Critically Ill Patients
por: Sánchez-Hurtado, Luis Alejandro, et al.
Publicado: (2018)

Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
por: Yanagi, Naoya, et al.
Publicado: (2021)

P1577: EVALUATION OF THE CLOT FORMATION TRANFUSING FRESH, COLD AND FROZEN PLATELETS. ADVANTAGES FOR THE MILITARY ENVIRONMENT
por: Díaz Valdés, José R., et al.
Publicado: (2023)

Time to look beyond one-year mortality in critically ill hematological patients?
por: Moors, Ine, et al.
Publicado: (2014)

Kinetics of blood neutrophil and lymphocyte count in critically ill neutropenic patients with hematological malignancies
por: Van de Louw, Andry
Publicado: (2021)

Patients with hematological malignancies admitted to intensive care units: new challenges for the intensivist
por: Torres, Viviane Bogado Leite, et al.
Publicado: (2015)

1577 In vitro polyfunctional CD4 T cell correlates of diagnostic tests for latent TB in HIV-infected subjects
por: Van Epps, Puja, et al.
Publicado: (2014)

LB1577. Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the Omicron Predominant Era (PRESTO)
por: Tuan, Jessica, et al.
Publicado: (2022)

Genetic Predisposition to Critical Illness in the Pediatric Intensive Care Unit
por: Thomas, Neal J., et al.
Publicado: (2011)

Intensive care unit burden is associated with increased mortality in critically ill COVID‐19 patients
por: Didriksson, Ingrid, et al.
Publicado: (2022)

Intensive insulin therapy and mortality in critically ill patients
por: Treggiari, Miriam M, et al.
Publicado: (2008)

Relative adrenal insufficiency in critically ill hematology patients
por: Cerman, J, et al.
Publicado: (2005)

Invasive aspergillosis in critically ill hematology patients: outcomes and prognostic factors associated with mortality
por: Burghi, G, et al.
Publicado: (2011)

Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study
por: Merz, Tobias M, et al.
Publicado: (2008)

Risk Factors and Outcomes in Critically Ill Patients with Hematological Malignancies Complicated by Hospital-Acquired Infections
por: Yerzhan, Adina, et al.
Publicado: (2023)

Risk Factors for Hospital and Long-Term Mortality of Critically Ill Elderly Patients Admitted to an Intensive Care Unit
por: Mukhopadhyay, A., et al.
Publicado: (2014)

Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with Intensive Care Unit mortality in critically ill
por: Sai Saran, P. V., et al.
Publicado: (2016)

Hematologic and oncologic complications in the critically ill child.
por: McIntosh, S.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_pavdjv4u8kh9vfrn85i5bbn7m5